Ongoing inflammation in children with rheumatic heart disease

Cardiology in the Young

Volumn 21, Issue 3, 2011, Pages 334-339

  Habeeb, Nevin M M ^a,b   Al Hadidi, Iman S ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

atherosclerosis; highly sensitive C reactive protein; homocysteine; Rheumatic mitral regurge

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ARTICLE; CARDITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LUNG ARTERY PRESSURE; MALE; MITRAL VALVE REGURGITATION; PATIENT CODING; PRESCHOOL CHILD; RHEUMATIC HEART DISEASE; SENSITIVITY ANALYSIS;

EID: 79956044037     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951111000047     Document Type: Article

References (20)

1. Rajamannan NM, Antonini-Canterin F, Moura L, et al. Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive? Indian heart J 2009; 61: 14-23.
2. Essop MR, Nkomo VT. Rheumatic and non rheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation 2005; 112: 3584-3591. (Pubitemid 43739536)
3. Chopra P, Gulwani H. Pathology and pathogenesis of rheumatic heart disease. Indian J Pathol Microbiol 2007; 50: 685-697. (Pubitemid 350305464)
4. Ridker PM, Buring JE, Shih J, Matias M, Hnnekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-733. (Pubitemid 28391836)
5. Ferrieri P. Jones criteria working group. Proceedings of the Jones criteria workshop. Circulation 2002; 106: 2521-2523. (Pubitemid 35278813)
6. Golbasi Z, Ucar O, Keles T, et al. Increased levels of sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 2002; 4: 593-595. (Pubitemid 35278511)
7. Chiu-Braga UU, Hayashi SY, Schafranski M, Messias-Reason IJ. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs- CRP). Int J Cardiol 2006; 1109: 275-276.
8. Davutoglu V, Celik A, Aksoy M. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis 2005; 14: 251-256. (Pubitemid 47046907)
9. Krasuski RA, Bush A, Kay JE, et al. C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. Am Heart J 2003; 146: 146-151.
10. Hingorani AD, Shah T, Casas JP, Humphries SE, Talmud PJ. C-reactive protein and coronary heart disease: predictive test or therapeutic target? Clin Chem 2009; 55: 239-255.
11. Zhang YX, Cliff WJ, Schoefi GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999; 145: 375-379. (Pubitemid 29359147)
12. de Beer FC, Soutar AK, Baltz ML, Trayner I, Feinstein A, Pepys MB. Low density and very low density lipoproteins are selectively bound by aggregated C-reactive protein. J Exp Med 1982; 156: 230-242. (Pubitemid 12082501)
13. Bhakdi S, Torzewski M, Klouche M, Hemmes M. Complement activation and atherogenesis. Binding of CRP to degraded, nonoxidised LDL enhances complement activation. Arterioscler Thromb Vasc Biol 1999; 19: 2348-2354. (Pubitemid 29477835)
14. Li BL, Li L, Hou XL, et al. Prevalence of coronary artery disease in patients with rheumatic heart disease in China. Zhonghua Yi Xue Za Zhi 2007; 87: 3313-3316. (Pubitemid 351356132)
15. Panamonta M, Settasatinan N, Kaplan EL, Chaikitpinyo A. Serum cholesterol levels in patients with acute rheumatic fever. Am J Dis Child 1993; 147: 732-736. (Pubitemid 23198450)
16. Yilmaz MB, Demirkan B, Caldir V, et al. Association of lipid profile with echocardiographic Wilkins score in patients with moderate to severe mitral stenosis: possible impact on prognosis. J Am Coll Cardiol 2009; 53: 1874-1879.
17. Antonini-Canteri F, Leiballi E, Enache R, et al. Hydroxymethylglutaryl coenzyme-a reductase inhibitors delay the progression of rheumatic aortic valve stenosis. A long-term echocardiographic study. J Am Coll Cardiol 2009; 53: 1874-1879.
18. Kurban S, Mehmetoglu I, Oran B, Kiyici A. Homocysteine levels and total antioxidant capacity in children with acute rheumatic fever. Clin Biochem 2007; 10: 26-29.
19. Wald DS, Law M, Marris KJ. Homocyseine and cardiovascular disease: evidence of causality from a meta-analysis. BMJ 2002; 325: 1202.
20. Cleophas TJ, Hornstra N, van Hoogstraten B, van der Meulen J. Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis. J Am Coll Cardiol 2000; 86: 1005-1009.